{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:49:58Z","timestamp":1794430198618,"version":"4.9.1"},"publisher-location":"Boston, MA","reference-count":51,"publisher":"Springer US","isbn-type":[{"value":"9781461441175","type":"print"},{"value":"9781461441182","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T00:00:00Z","timestamp":1344556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-4614-4118-2_17","type":"book-chapter","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T17:26:08Z","timestamp":1347989168000},"page":"247-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Targeting Complement at the Time of Transplantation"],"prefix":"10.1007","author":[{"given":"Steven","family":"Sacks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Karegli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad A.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Schwaeble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuding","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,10]]},"reference":[{"key":"17_CR1","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4049\/jimmunol.149.4.1348","volume":"149","author":"M Botto","year":"1992","unstructured":"Botto M, Lissandrini D, Sorio C, Walport MJ (1992) Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J Immunol 149:1348\u20131355","journal-title":"J Immunol"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1749-6632.1979.tb47142.x","volume":"332","author":"HR Colten","year":"1979","unstructured":"Colten HR, Ooi YM, Edelson PJ (1979) Synthesis and secretion of complement proteins by macrophages. Ann N Y Acad Sci 332:482\u2013490","journal-title":"Ann N Y Acad Sci"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nri1702","volume":"5","author":"RB Colvin","year":"2005","unstructured":"Colvin RB, Smith RN (2005) Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5:807\u2013817","journal-title":"Nat Rev Immunol"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/TP.0b013e318222c9a0","volume":"92","author":"J Damman","year":"2011","unstructured":"Damman J, Seelen MA, Moers C, Daha MR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ (2011a) Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation 92:163\u2013169","journal-title":"Transplantation"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/ndt\/gfq717","volume":"26","author":"J Damman","year":"2011","unstructured":"Damman J, Nijboer WN, Schuurs TA, Leuvenink HG, Morariu AM, Tullius SG, van Goor H, Ploeg RJ, Seelen MA (2011b) Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. Nephrol Dial Transplant 26:2345\u20132354","journal-title":"Nephrol Dial Transplant"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.4049\/jimmunol.170.7.3883","volume":"170","author":"B Vries de","year":"2003","unstructured":"de Vries B, Kohl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P, Buurman WA (2003) Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 170:3883\u20133889","journal-title":"J Immunol"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1126\/science.271.5247.348","volume":"271","author":"PW Dempsey","year":"1996","unstructured":"Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348\u2013350","journal-title":"Science"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/prep.1995.0003","volume":"6","author":"I Dodd","year":"1995","unstructured":"Dodd I, Mossakowska DE, Camilleri P, Haran M, Hensley P, Lawlor EJ, McBay DL, Pindar W, Smith RA (1995) Overexpression in Escherichia coli, folding, purification, and characterization of the first three short consensus repeat modules of human complement receptor type 1. Protein Expr Purif 6:727\u2013736","journal-title":"Protein Expr Purif"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1096\/fj.05-4747com","volume":"20","author":"CA Farrar","year":"2006","unstructured":"Farrar CA, Zhou W, Lin T, Sacks SH (2006) Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J 20:217\u2013226","journal-title":"FASEB J"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.157.2.549","volume":"157","author":"MB Fischer","year":"1996","unstructured":"Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL, Kremmer E, Rosen FS, Carroll MC (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157:549\u2013556","journal-title":"J Immunol"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/intimm\/10.12.1923","volume":"10","author":"K Kerekes","year":"1998","unstructured":"Kerekes K, Prechl J, Bajtay Z, Jozsi M, Erdei A (1998) A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int Immunol 10:1923\u20131930","journal-title":"Int Immunol"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/TP.0b013e3181889831","volume":"86","author":"K Keslar","year":"2008","unstructured":"Keslar K, Rodriguez ER, Tan CD, Starling RC, Heeger PS (2008) Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury. Transplantation 86:1319\u20131321","journal-title":"Transplantation"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood-2008-04-151068","volume":"112","author":"PN Lalli","year":"2008","unstructured":"Lalli PN, Strainic MG, Yang M, Lin F, Medof ME, Heeger PS (2008) Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 112:1759\u20131766","journal-title":"Blood"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nm1251","volume":"11","author":"RI Lechler","year":"2005","unstructured":"Lechler RI, Sykes M, Thomson AW, Turka LA (2005) Organ transplantation \u2013 how much of the promise has been realized? Nat Med 11:605\u2013613","journal-title":"Nat Med"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2249.2008.03678.x","volume":"153","author":"AG Lewis","year":"2008","unstructured":"Lewis AG, Kohl G, Ma Q, Devarajan P, Kohl J (2008) Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. Clin Exp Immunol 153:117\u2013126","journal-title":"Clin Exp Immunol"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.4049\/jimmunol.177.4.2543","volume":"177","author":"K Li","year":"2006","unstructured":"Li K, Feito MJ, Sacks SH, Sheerin NS (2006) CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli. J Immunol 177:2543\u20132551","journal-title":"J Immunol"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1016\/j.molimm.2007.06.006","volume":"44","author":"K Li","year":"2007","unstructured":"Li K, Sacks SH, Zhou W (2007) The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol 44:3866\u20133874","journal-title":"Mol Immunol"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1681\/ASN.2009090977","volume":"21","author":"Q Li","year":"2010","unstructured":"Li Q, Peng Q, Xing G, Li K, Wang N, Farrar CA, Meader L, Sacks SH, Zhou W (2010) Deficiency of C5aR prolongs renal allograft survival. J Am Soc Nephrol 21:1344\u20131353","journal-title":"J Am Soc Nephrol"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-4899-2418-6_20","volume":"340","author":"JM Maraganore","year":"1993","unstructured":"Maraganore JM (1993) Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitor. Adv Exp Med Biol 340:227\u2013236","journal-title":"Adv Exp Med Biol"},{"issue":"13","key":"17_CR20","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.molimm.2010.05.027","volume":"47","author":"T Melchionna","year":"2010","unstructured":"Melchionna T, Karegli J, Farrar CA, McVey JH, Dorling A, Sacks SH, Smith RAG (2010) Integrating cytotopic strategy in transplantation: (1) Design of locally-acting coagulation inhibitors for use with anti-complement therapeutics. Mol Immunol 47(13):2203, Ref Type: Abstract","journal-title":"Mol Immunol"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1681\/ASN.2008111145","volume":"20","author":"M Naesens","year":"2009","unstructured":"Naesens M, Li L, Ying L, Sansanwal P, Sigdel TK, Hsieh SC, Kambham N, Lerut E, Salvatierra O, Butte AJ, Sarwal MM (2009) Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol 20:1839\u20131851","journal-title":"J Am Soc Nephrol"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0161-5890(90)90141-L","volume":"27","author":"P Pantazis","year":"1990","unstructured":"Pantazis P, Kalyanaraman VS, Bing DH (1990) Synthesis of the third component of complement (C3) by lectin-activated and HTLV-infected human T-cells. Mol Immunol 27:283\u2013289","journal-title":"Mol Immunol"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1681\/ASN.2005101116","volume":"17","author":"H Patel","year":"2006","unstructured":"Patel H, Smith RA, Sacks SH, Zhou W (2006) Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage. J Am Soc Nephrol 17:1102\u20131111","journal-title":"J Am Soc Nephrol"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.4049\/jimmunol.176.6.3330","volume":"176","author":"Q Peng","year":"2006","unstructured":"Peng Q, Li K, Patel H, Sacks SH, Zhou W (2006) Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J Immunol 176:3330\u20133341","journal-title":"J Immunol"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1182\/blood-2007-06-095018","volume":"111","author":"Q Peng","year":"2008","unstructured":"Peng Q, Li K, Anderson K, Farrar CA, Lu B, Smith RA, Sacks SH, Zhou W (2008) Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a\u2013C3aR interaction. Blood 111:2452\u20132461","journal-title":"Blood"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.4049\/jimmunol.0804186","volume":"183","author":"Q Peng","year":"2009","unstructured":"Peng Q, Li K, Wang N, Li Q, Asgari E, Lu B, Woodruff TM, Sacks SH, Zhou W (2009) Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol 183:6058\u20136068","journal-title":"J Immunol"},{"key":"17_CR27","first-page":"2055","volume":"149","author":"JR Pratt","year":"1996","unstructured":"Pratt JR, Hibbs MJ, Laver AJ, Smith RA, Sacks SH (1996) Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol 149:2055\u20132066","journal-title":"Am J Pathol"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nm0602-582","volume":"8","author":"JR Pratt","year":"2002","unstructured":"Pratt JR, Basheer SA, Sacks SH (2002) Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8:582\u2013587","journal-title":"Nat Med"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0002-9440(10)63503-1","volume":"163","author":"JR Pratt","year":"2003","unstructured":"Pratt JR, Jones ME, Dong J, Zhou W, Chowdhury P, Smith RA, Sacks SH (2003) Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia\/reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol 163:1457\u20131465","journal-title":"Am J Pathol"},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/nbt1342","volume":"25","author":"D Ricklin","year":"2007","unstructured":"Ricklin D, Lambris JD (2007) Complement-targeted therapeutics. Nat Biotechnol 25:1265\u20131275","journal-title":"Nat Biotechnol"},{"key":"17_CR31","first-page":"273","volume":"632","author":"D Ricklin","year":"2008","unstructured":"Ricklin D, Lambris JD (2008) Compstatin: a complement inhibitor on its way to clinical application. Adv Exp Med Biol 632:273\u2013292","journal-title":"Adv Exp Med Biol"},{"key":"17_CR32","first-page":"364","volume":"2","author":"P Rioux","year":"2001","unstructured":"Rioux P (2001) TP-10 (AVANT Immunotherapeutics). Curr Opin Investig Drugs 2:364\u2013371","journal-title":"Curr Opin Investig Drugs"},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-065X.2007.00556.x","volume":"219","author":"R Roozendaal","year":"2007","unstructured":"Roozendaal R, Carroll MC (2007) Complement receptors CD21 and CD35 in humoral immunity. Immunol Rev 219:157\u2013166","journal-title":"Immunol Rev"},{"key":"17_CR34","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1073\/pnas.1101748108","volume":"108","author":"WJ Schwaeble","year":"2011","unstructured":"Schwaeble WJ, Lynch NJ, Clark JE, Marber M, Samani NJ, Ali YM, Dudler T, Parent B, Lhotta K, Wallis R, Farrar CA, Sacks S, Lee H, Zhang M, Iwaki D, Takahashi M, Fujita T, Tedford CE, Stover CM (2011) Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia\/reperfusion injury. Proc Natl Acad Sci USA 108:7523\u20137528","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1172\/JCI25982","volume":"116","author":"B Selander","year":"2006","unstructured":"Selander B, Martensson U, Weintraub A, Holmstrom E, Matsushita M, Thiel S, Jensenius JC, Truedsson L, Sjoholm AG (2006) Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest 116:1425\u20131434","journal-title":"J Clin Invest"},{"key":"17_CR36","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1042\/BST0301037","volume":"30","author":"RA Smith","year":"2002","unstructured":"Smith RA (2002) Targeting anticomplement agents. Biochem Soc Trans 30:1037\u20131041","journal-title":"Biochem Soc Trans"},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0161-5890(01)00047-5","volume":"38","author":"RA Smith","year":"2001","unstructured":"Smith RA, Dodd I, Oldroyd RG, Harry J, Clark C, Rolan P, Dawes L (2001) Preclinical and clinical progression of a membrane-targeted complement regulator therapeutic. Mol Immunol 38:122, Ref Type: Abstract","journal-title":"Mol Immunol"},{"issue":"16","key":"17_CR38","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1016\/j.molimm.2007.06.021","volume":"44","author":"RAG Smith","year":"2007","unstructured":"Smith RAG, Koffman G, Chowdhury P, Smith KCG, Watson CJ, Nicholson ML, Zhou W, Sacks SH (2007) Membrane-localising complement inhibitors \u2013 clinical progress. Mol Immunol 44(16):3915, Ref Type: Abstract","journal-title":"Mol Immunol"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","volume":"8","author":"K Solez","year":"2008","unstructured":"Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M (2008) Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8:753\u2013760","journal-title":"Am J Transplant"},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/89923","volume":"7","author":"T Springall","year":"2001","unstructured":"Springall T, Sheerin NS, Abe K, Holers VM, Wan H, Sacks SH (2001) Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat Med 7:801\u2013806","journal-title":"Nat Med"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","volume":"28","author":"MG Strainic","year":"2008","unstructured":"Strainic MG, Liu J, Huang D, An F, Lalli PN, Muqim N, Shapiro VS, Dubyak GR, Heeger PS, Medof ME (2008) Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28:425\u2013435","journal-title":"Immunity"},{"key":"17_CR42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.V10169","volume":"10","author":"S Tang","year":"1999","unstructured":"Tang S, Sheerin NS, Zhou W, Brown Z, Sacks SH (1999a) Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. J Am Soc Nephrol 10:69\u201376","journal-title":"J Am Soc Nephrol"},{"key":"17_CR43","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.4049\/jimmunol.162.7.4336","volume":"162","author":"S Tang","year":"1999","unstructured":"Tang S, Zhou W, Sheerin NS, Vaughan RW, Sacks SH (1999b) Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol 162:4336\u20134341","journal-title":"J Immunol"},{"key":"17_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI24521","volume":"116","author":"JM Thurman","year":"2006","unstructured":"Thurman JM, Ljubanovic D, Royer PA, Kraus DM, Molina H, Barry NP, Proctor G, Levi M, Holers VM (2006) Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia\/reperfusion. J Clin Invest 116:357\u2013368","journal-title":"J Clin Invest"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1084\/jem.183.5.2343","volume":"183","author":"MR Weiser","year":"1996","unstructured":"Weiser MR, Williams JP, Moore FD Jr, Kobzik L, Ma M, Hechtman HB, Carroll MC (1996) Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183:2343\u20132348","journal-title":"J Exp Med"},{"key":"17_CR46","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1126\/science.2371562","volume":"249","author":"HF Weisman","year":"1990","unstructured":"Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146\u2013151","journal-title":"Science"},{"key":"17_CR55","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1111\/j.1600-6143.2006.01427.x","volume":"6","author":"X Zheng","year":"2006","unstructured":"Zhang M, Austen WG Jr, Chiu I, Alicot EM, Hung R, Ma M, Verna N, Xu M, Hechtman HB, Moore FD Jr, and Carroll MC (2004). Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia\/reperfusion injury. Proc Natl Acad Sci USA 101:3886","journal-title":"Am J Transplant"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1111\/j.1600-6143.2006.01427.x","volume":"6","author":"X Zheng","year":"2006","unstructured":"Zheng X, Feng B, Chen G, Zhang X, Li M, Sun H, Liu W, Vladau C, Liu R, Jevnikar AM, Garcia B, Zhong R, Min WP (2006) Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant 6:2099\u20132108","journal-title":"Am J Transplant"},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2353\/ajpath.2008.080103","volume":"173","author":"X Zheng","year":"2008","unstructured":"Zheng X, Zhang X, Feng B, Sun H, Suzuki M, Ichim T, Kubo N, Wong A, Min LR, Budohn ME, Garcia B, Jevnikar AM, Min WP (2008) Gene silencing of complement C5a receptor using siRNA for preventing ischemia\/reperfusion injury. Am J Pathol 173:973\u2013980","journal-title":"Am J Pathol"},{"key":"17_CR49","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI8621","volume":"105","author":"W Zhou","year":"2000","unstructured":"Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH (2000) Predominant role for C5b-9 in renal ischemia\/reperfusion injury. J Clin Invest 105:1363\u20131371","journal-title":"J Clin Invest"},{"key":"17_CR50","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1182\/blood-2005-08-3144","volume":"107","author":"W Zhou","year":"2006","unstructured":"Zhou W, Patel H, Li K, Peng Q, Villiers MB, Sacks SH (2006) Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 107:2461\u20132469","journal-title":"Blood"}],"container-title":["Advances in Experimental Medicine and Biology","Complement Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-4118-2_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T17:31:26Z","timestamp":1687714286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-4118-2_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,10]]},"ISBN":["9781461441175","9781461441182"],"references-count":51,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-4118-2_17","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4614-4118-2","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,10]]},"assertion":[{"value":"10 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}